The SURMOUNT-5 trial, published in The New England Journal of Medicine in May 2025, is the first large randomized study to compare tirzepatide and semaglutide directly in adults with obesity
Changes in body composition, clinical, biochemical and immunological outcomes after 6 months of zinc or/and selenium supplementation All the individuals that were included in the present analysis completed the supplementation with more than 90% of adherence to the zinc and/or selenium treatment during the entire time of the intervention
Presented for research literature review only Luo Y et al
RELATED: New GLP-1 drugs could suppress desire for more than just food, study suggests Big picture view: The rapid rise in GLP-1 usage continues to align with broader improvements in national health, particularly aiding in lowering obesity rates
Sodium-glucose cotransporter 2 inhibitors and risk of hyperkalemia in people with type 2 diabetes: a meta-analysis of individual participant data from randomized, controlled trials
Lets dive into the numbers and letters that can be seen in the label of the li-po battery packs